Adenosine 2',3'-cyclic phosphate

Metabolite details

Identifier

KMYWVDDIPVNLME-UHFFFAOYSA-N

InChI Key

KMYWVDDIPVNLME-UHFFFAOYSA-N

IUPAC name

[4-(6-aminopurin-9-yl)-2-hydroxy-2-oxo-3a,4,6,6a-tetrahydrouro[3,4-d][1,3,2]dioxaphosphol-6-yl]methanol

Preferred name

Adenosine 2',3'-cyclic phosphate

INN name

—

Synonym

—

ChEBI

CHEBI:175195

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Bioaccumulation of therapeutic drugs by human gut bacteria: cross-feeding metabolite analysis (FIA-MS) (E.rectale;S.salivarius assays)
• Bioplatforms Australia: Antibiotic Resistant Sepsis Pathogens Framework Initiative (Escherichia coli assays)
• Metabolic Dynamics of In Vitro CD8+ T Cell Activation.
• Bioplatforms Australia: Antibiotic Resistant Sepsis Pathogens Framework Initiative (Klebsiella pneumoniae assays)

Observed in differential profiles

• G4_Eubacterium_rectale_DMSO_30_vs_G3_Eubacterium_rectale_Duloxetine_47
• RPMI_B36_vs_Pooled_Sera_B36
• G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h
• G1_Klebsiella_pneumoniae_AJ218_RPMI_vs_G2_Klebsiella_pneumoniae_AJ218_Pooled_sera